Research ArticleResearch Article

Ability of a Specific ERK Signal-Pathway Inhibitor to Reverse P-Glycoprotein-Mediated Vincristine Resistance in Colon Cancer Cell Lines

Feng Jin, Hua Fan, Bo Chen, Ping Lu, Fan Yao, Huimian Xu and Shubao Wang
Chinese Journal of Clinical Oncology August 2004, 1 (4) 295-300;

Article Information

vol. 1 no. 4 295-300
Published By 
Cancer Biology & Medicine
History 
  • Received February 19, 2004
  • Accepted August 19, 2004
  • Published online August 1, 2004.
Copyright & Usage 
Copyright © 2004 by Tianjin Medical University Cancer Institute & Hospital and Springer

Author Information

  1. Feng Jin1⇑
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Correspondence to: Feng Jin Tel: 86-24-8163-5662 (PHS) 86-13066609098 (Mobil) Fax:86-24-8856-7050 E-mail: Jinfeng66cn{at}hotmail.com
  1. Hua Fan2
  1. 2Department of Internal Medicine and Hematology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Bo Chen1
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Ping Lu1
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Fan Yao1
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Huimian Xu1
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
  1. Shubao Wang1
  1. 1Department of Surgical Oncology, the First Affiliated Hospital, China Medical University, Shenyang 110001, China.
Back to top

In this issue

Download PDF
Email Article
Citation Tools

Jump to section

Keywords